Cargando…

Quality of information offered to women by drug sellers providing medical abortion in Nigeria: Evidence from providers and their clients

BACKGROUND: Evidence confirmed that the demand for medical abortion (MA) increased significantly during the COVID-19 outbreak in many developing countries including Nigeria. In an abortion-restrictive setting like Nigeria, local pharmacies, and proprietary patent medicine vendors (PPMVs) continue to...

Descripción completa

Detalles Bibliográficos
Autores principales: Akinyemi, Akanni, Owolabi, Onikepe Oluwadamilola, Erinfolami, Temitope, Stillman, Melissa, Bankole, Akinrinola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428275/
https://www.ncbi.nlm.nih.gov/pubmed/36060610
http://dx.doi.org/10.3389/fgwh.2022.899662
_version_ 1784779078302171136
author Akinyemi, Akanni
Owolabi, Onikepe Oluwadamilola
Erinfolami, Temitope
Stillman, Melissa
Bankole, Akinrinola
author_facet Akinyemi, Akanni
Owolabi, Onikepe Oluwadamilola
Erinfolami, Temitope
Stillman, Melissa
Bankole, Akinrinola
author_sort Akinyemi, Akanni
collection PubMed
description BACKGROUND: Evidence confirmed that the demand for medical abortion (MA) increased significantly during the COVID-19 outbreak in many developing countries including Nigeria. In an abortion-restrictive setting like Nigeria, local pharmacies, and proprietary patent medicine vendors (PPMVs) continue to play a major role in the provision of MA including misoprostol. There is the need to understand these providers' knowledge about the use of misoprostol for abortion and the quality of information they provide to their clients. This analysis is focused on assessing the quality of care provided by both drug seller types, from drug sellers' and women's perspectives. METHODOLOGY: This study utilized primary data collected from drug sellers (pharmacists and PPMVs) and women across 6 Local Government Areas in Lagos State, Nigeria. The core sample included 126 drug sellers who had sold abortion-inducing drugs and 386 women who procured abortion-inducing drugs from the drug sellers during the time of the study. We calculate quality-of-care indices for the care women received from drug sellers, drawing on WHO guidelines for medication abortion provision. The index based on information from the sellers had two domains—technical competency and information provided to clients, while the index from the women's perspectives includes an additional domain, client experience. RESULTS: Results show that the majority of drug sellers in the sample, 56% (n = 70), were pharmacists. However, far more than half of women 60% (n = 233) had visited PPMVs. Overall, the total quality score amongst all drug sellers (mean 0.48, SD0.15) was higher than the total score calculated based on women's responses (mean 0.39, SD 0.21). Using our quality-of-care index, pharmacies and PPMVs seem to have similar technical competency (mean score of 0.23, SD 0.13 in both groups (range 0–1), whilst PPMV's performed better on the information provided to client domain (mean score of 0.79, SD 0.17 compared with pharmacies 0.69, SD 0.25). Based on women's reports, PPMVs scored better on both quality of care domains (technical competency and information provided to clients) compared with pharmacies. PROGRAM/POLICY IMPLICATION: In resource-constrained settings such as Nigeria, particularly in the context of health emergencies like COVID-19, there is the need to continue to strengthen and engage PPMVs' capacity and skills in dispensing and administration of MA drugs as a harm reduction strategy. Also, there is the need to target frontline providers in pharmacies for training and skill upscale in MA provision.
format Online
Article
Text
id pubmed-9428275
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94282752022-09-01 Quality of information offered to women by drug sellers providing medical abortion in Nigeria: Evidence from providers and their clients Akinyemi, Akanni Owolabi, Onikepe Oluwadamilola Erinfolami, Temitope Stillman, Melissa Bankole, Akinrinola Front Glob Womens Health Global Women's Health BACKGROUND: Evidence confirmed that the demand for medical abortion (MA) increased significantly during the COVID-19 outbreak in many developing countries including Nigeria. In an abortion-restrictive setting like Nigeria, local pharmacies, and proprietary patent medicine vendors (PPMVs) continue to play a major role in the provision of MA including misoprostol. There is the need to understand these providers' knowledge about the use of misoprostol for abortion and the quality of information they provide to their clients. This analysis is focused on assessing the quality of care provided by both drug seller types, from drug sellers' and women's perspectives. METHODOLOGY: This study utilized primary data collected from drug sellers (pharmacists and PPMVs) and women across 6 Local Government Areas in Lagos State, Nigeria. The core sample included 126 drug sellers who had sold abortion-inducing drugs and 386 women who procured abortion-inducing drugs from the drug sellers during the time of the study. We calculate quality-of-care indices for the care women received from drug sellers, drawing on WHO guidelines for medication abortion provision. The index based on information from the sellers had two domains—technical competency and information provided to clients, while the index from the women's perspectives includes an additional domain, client experience. RESULTS: Results show that the majority of drug sellers in the sample, 56% (n = 70), were pharmacists. However, far more than half of women 60% (n = 233) had visited PPMVs. Overall, the total quality score amongst all drug sellers (mean 0.48, SD0.15) was higher than the total score calculated based on women's responses (mean 0.39, SD 0.21). Using our quality-of-care index, pharmacies and PPMVs seem to have similar technical competency (mean score of 0.23, SD 0.13 in both groups (range 0–1), whilst PPMV's performed better on the information provided to client domain (mean score of 0.79, SD 0.17 compared with pharmacies 0.69, SD 0.25). Based on women's reports, PPMVs scored better on both quality of care domains (technical competency and information provided to clients) compared with pharmacies. PROGRAM/POLICY IMPLICATION: In resource-constrained settings such as Nigeria, particularly in the context of health emergencies like COVID-19, there is the need to continue to strengthen and engage PPMVs' capacity and skills in dispensing and administration of MA drugs as a harm reduction strategy. Also, there is the need to target frontline providers in pharmacies for training and skill upscale in MA provision. Frontiers Media S.A. 2022-08-17 /pmc/articles/PMC9428275/ /pubmed/36060610 http://dx.doi.org/10.3389/fgwh.2022.899662 Text en Copyright © 2022 Akinyemi, Owolabi, Erinfolami, Stillman and Bankole. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Global Women's Health
Akinyemi, Akanni
Owolabi, Onikepe Oluwadamilola
Erinfolami, Temitope
Stillman, Melissa
Bankole, Akinrinola
Quality of information offered to women by drug sellers providing medical abortion in Nigeria: Evidence from providers and their clients
title Quality of information offered to women by drug sellers providing medical abortion in Nigeria: Evidence from providers and their clients
title_full Quality of information offered to women by drug sellers providing medical abortion in Nigeria: Evidence from providers and their clients
title_fullStr Quality of information offered to women by drug sellers providing medical abortion in Nigeria: Evidence from providers and their clients
title_full_unstemmed Quality of information offered to women by drug sellers providing medical abortion in Nigeria: Evidence from providers and their clients
title_short Quality of information offered to women by drug sellers providing medical abortion in Nigeria: Evidence from providers and their clients
title_sort quality of information offered to women by drug sellers providing medical abortion in nigeria: evidence from providers and their clients
topic Global Women's Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428275/
https://www.ncbi.nlm.nih.gov/pubmed/36060610
http://dx.doi.org/10.3389/fgwh.2022.899662
work_keys_str_mv AT akinyemiakanni qualityofinformationofferedtowomenbydrugsellersprovidingmedicalabortioninnigeriaevidencefromprovidersandtheirclients
AT owolabionikepeoluwadamilola qualityofinformationofferedtowomenbydrugsellersprovidingmedicalabortioninnigeriaevidencefromprovidersandtheirclients
AT erinfolamitemitope qualityofinformationofferedtowomenbydrugsellersprovidingmedicalabortioninnigeriaevidencefromprovidersandtheirclients
AT stillmanmelissa qualityofinformationofferedtowomenbydrugsellersprovidingmedicalabortioninnigeriaevidencefromprovidersandtheirclients
AT bankoleakinrinola qualityofinformationofferedtowomenbydrugsellersprovidingmedicalabortioninnigeriaevidencefromprovidersandtheirclients